Guidelines for monitoring of anthracycline cardiomyopathy: a rebuttal

Pediatrics. 1994 Nov;94(5):782-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Child
  • Heart / drug effects
  • Heart Function Tests
  • Humans
  • Monitoring, Physiologic
  • Neoplasms / drug therapy*

Substances

  • Antibiotics, Antineoplastic